Dynamic Healthcare M&A Database

Acquiring Party	MEDRAD, Inc., a leading provider of contrast injection systems used to diagnose cardiovascular and other diseases and an affiliate of Bayer AG.
Transferring Party	Possis Medical, Inc., a leading provider of mechanical thrombectomy devices used to treat narrowed or blocked arteries and veins.
Sector	Medical Devices
Date	April 8, 2008
Analysis Furthers MEDRAD’s commitment to the growing cardiovascular intervention field, involving > 80m people with some form of cardiovascular disease. Synergies include compatible sales organizations and shared customer groups, as well as MEDRAD’s international distribution infrastructure offering expansion opportunities for Possis' products. There is a complimentary focus on high pressure intravascular fluid management. Deal vaue -- $361m on sales of $70.0m (5.1x) and EBITDA of $2.5m (144.4x).
The Walden Group is a leading healthcare investment banking firm specializing in mergers, acquisitions and strategic transactions. It also invests its own funds and, together with its expert operational partners, provides value-added services to help special companies reach critical milestones. This information is copyright © 2004-2007 The Walden Group, Inc. This information is provided as a service to the public but remains the intellectual property of The Walden Group, Inc and may not be reproduced in any manner without the written permission of The Walden Group, Inc. The information contained in the transactions table was derived from publicly available and other sources. Transaction analysis and other information are based, in part, upon public comments, Walden Group research and judgments, and reporting and research of others. The information is not intended to be relied upon as pronouncements by the transaction participants or for any other reason.

Dynamic Healthcare M&A Database - 2Q08